Moreover, JUNB (JunB proto-oncogene) and NR4A1 (nuclear receptor subfamily 4 group A member 1 gene) can also regulate the functional state of T cells in the TIME, serving as targets of tumor immunotherapy (86, 87). Here, NR4A1 is linked to neoplasm.